You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
|
|---|---|
| Published in |
Lancet Oncology, October 2020
|
| DOI | 10.1016/s1470-2045(20)30451-4 |
| Pubmed ID | |
| Authors |
Mrinal Gounder, Patrick Schöffski, Robin L Jones, Mark Agulnik, Gregory M Cote, Victor M Villalobos, Steven Attia, Rashmi Chugh, Tom Wei-Wu Chen, Thierry Jahan, Elizabeth T Loggers, Abha Gupta, Antoine Italiano, George D Demetri, Ravin Ratan, Lara E Davis, Olivier Mir, Palma Dileo, Brian A Van Tine, Joseph G Pressey, Trupti Lingaraj, Anand Rajarethinam, Laura Sierra, Shefali Agarwal, Silvia Stacchiotti |
X Demographics
The data shown below were collected from the profiles of 48 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 17 | 35% |
| France | 3 | 6% |
| Germany | 3 | 6% |
| Italy | 2 | 4% |
| Spain | 2 | 4% |
| Mexico | 2 | 4% |
| United Kingdom | 2 | 4% |
| Belgium | 2 | 4% |
| Australia | 1 | 2% |
| Other | 2 | 4% |
| Unknown | 12 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 67% |
| Scientists | 7 | 15% |
| Practitioners (doctors, other healthcare professionals) | 7 | 15% |
| Science communicators (journalists, bloggers, editors) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 137 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 14% |
| Student > Master | 17 | 12% |
| Student > Bachelor | 13 | 9% |
| Student > Ph. D. Student | 11 | 8% |
| Other | 6 | 4% |
| Other | 18 | 13% |
| Unknown | 53 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 26% |
| Biochemistry, Genetics and Molecular Biology | 15 | 11% |
| Agricultural and Biological Sciences | 5 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Chemistry | 5 | 4% |
| Other | 17 | 12% |
| Unknown | 55 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 299. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2024.
All research outputs
#117,860
of 25,743,152 outputs
Outputs from Lancet Oncology
#126
of 6,937 outputs
Outputs of similar age
#3,573
of 436,548 outputs
Outputs of similar age from Lancet Oncology
#3
of 101 outputs
Altmetric has tracked 25,743,152 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,937 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,548 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.